Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,301 | -3,362 | -9,568 | -10,204 | -6,049 |
| Depreciation Amortization | 2 | 2 | 7 | 5 | 3 |
| Income taxes - deferred | N/A | N/A | -3,199 | -2,181 | -1,576 |
| Accounts receivable | 106 | 106 | 596 | 421 | 307 |
| Accounts payable and accrued liabilities | -356 | 711 | -84 | 287 | 990 |
| Other Working Capital | -213 | 770 | 342 | 408 | 1,103 |
| Other Operating Activity | -182 | -28 | -2,998 | -686 | -2,613 |
| Operating Cash Flow | $-4,944 | $-1,801 | $-14,904 | $-11,950 | $-7,835 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 0 | -15 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $-15 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 14,999 | N/A | N/A |
| Other Financing Activity | -327 | -327 | -967 | 0 | 0 |
| Financing Cash Flow | $-327 | $-327 | $14,032 | $N/A | $N/A |
| Beginning Cash Position | 22,133 | 22,133 | 23,005 | 23,005 | 23,005 |
| End Cash Position | 16,862 | 20,005 | 22,133 | 11,055 | 15,155 |
| Net Cash Flow | $-5,271 | $-2,128 | $-872 | $-11,950 | $-7,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,944 | -1,801 | -14,904 | -11,950 | -7,835 |
| Free Cash Flow | -4,944 | -1,801 | -14,904 | -11,950 | -7,835 |